Casey Sederman

This paper introduces ScreenDL, a deep learning model that predicts effective cancer therapies using tumor omic and drug screening data, outperforming existing methods in preclinical trials.

This study identifies clinical features preceding genetic epilepsy diagnosis in EMR data from 32,000 individuals, showing early signs can inform earlier treatment.